1. Home
  2. ACHV vs GAIN Comparison

ACHV vs GAIN Comparison

Compare ACHV & GAIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

HOLD

Current Price

$8.18

Market Cap

726.5M

Sector

Health Care

ML Signal

HOLD

Logo Gladstone Investment Corporation Business Development Company

GAIN

Gladstone Investment Corporation Business Development Company

HOLD

Current Price

$15.86

Market Cap

651.5M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACHV
GAIN
Founded
N/A
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
726.5M
651.5M
IPO Year
2018
2005

Fundamental Metrics

Financial Performance
Metric
ACHV
GAIN
Price
$8.18
$15.86
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
2
Target Price
$14.67
$14.75
AVG Volume (30 Days)
1.4M
149.8K
Earning Date
05-11-2026
05-12-2026
Dividend Yield
N/A
9.19%
EPS Growth
N/A
20.63
EPS
N/A
0.76
Revenue
N/A
N/A
Revenue This Year
N/A
$9.07
Revenue Next Year
N/A
$7.32
P/E Ratio
N/A
$20.84
Revenue Growth
N/A
N/A
52 Week Low
$2.62
$13.14
52 Week High
$8.64
$17.14

Technical Indicators

Market Signals
Indicator
ACHV
GAIN
Relative Strength Index (RSI) 60.88 37.54
Support Level $4.03 $15.78
Resistance Level $8.63 $16.94
Average True Range (ATR) 0.37 0.26
MACD -0.01 -0.04
Stochastic Oscillator 75.46 11.90

Price Performance

Historical Comparison
ACHV
GAIN

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

About GAIN Gladstone Investment Corporation Business Development Company

Gladstone Investment Corp operates as an externally managed, closed-end, non-diversified management investment company. Its objective is to invest in debt and equity securities of established private businesses operating in the U.S., to achieve and grow current income by investing in debt securities of established businesses, and to provide stockholders with long-term capital appreciation in the value of its assets by investing in equity securities of established businesses. It focuses on investing in lower-middle-market private businesses.

Share on Social Networks: